Q3 Earnings Estimate for McKesson Issued By Leerink Partnrs

McKesson Co. (NYSE:MCK) – Equities research analysts at Leerink Partnrs reduced their Q3 2025 earnings estimates for McKesson in a research note issued on Thursday, December 5th. Leerink Partnrs analyst M. Cherny now expects that the company will earn $8.13 per share for the quarter, down from their previous estimate of $8.87. The consensus estimate for McKesson’s current full-year earnings is $32.73 per share. Leerink Partnrs also issued estimates for McKesson’s Q4 2025 earnings at $9.86 EPS.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, topping analysts’ consensus estimates of $6.88 by $0.19. The company had revenue of $93.65 billion for the quarter, compared to analyst estimates of $89.33 billion. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The business’s revenue for the quarter was up 21.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.23 EPS.

Several other research analysts have also weighed in on MCK. Baird R W upgraded shares of McKesson from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 7th. Leerink Partners cut their price target on shares of McKesson from $665.00 to $630.00 and set an “outperform” rating on the stock in a research note on Monday, October 7th. Robert W. Baird raised shares of McKesson from a “neutral” rating to an “outperform” rating and boosted their price objective for the company from $531.00 to $688.00 in a research note on Thursday, November 7th. Evercore ISI upped their price objective on McKesson from $560.00 to $680.00 and gave the stock an “outperform” rating in a report on Thursday, November 7th. Finally, StockNews.com upgraded McKesson from a “hold” rating to a “buy” rating in a report on Wednesday, November 6th. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $635.86.

McKesson Trading Down 0.7 %

NYSE MCK opened at $603.53 on Monday. The company has a market capitalization of $76.61 billion, a PE ratio of 31.25, a price-to-earnings-growth ratio of 1.32 and a beta of 0.49. The business’s 50-day moving average price is $554.83 and its 200 day moving average price is $561.91. McKesson has a twelve month low of $431.35 and a twelve month high of $637.51.

Institutional Investors Weigh In On McKesson

Large investors have recently added to or reduced their stakes in the company. Distillate Capital Partners LLC boosted its position in McKesson by 127,542.9% in the 2nd quarter. Distillate Capital Partners LLC now owns 35,740 shares of the company’s stock valued at $20,874,000 after buying an additional 35,712 shares during the last quarter. Chase Investment Counsel Corp boosted its holdings in McKesson by 50.8% in the second quarter. Chase Investment Counsel Corp now owns 8,985 shares of the company’s stock valued at $5,247,000 after purchasing an additional 3,027 shares during the last quarter. Wealthspire Advisors LLC grew its stake in McKesson by 8.9% during the 2nd quarter. Wealthspire Advisors LLC now owns 1,623 shares of the company’s stock valued at $948,000 after purchasing an additional 133 shares in the last quarter. Vaughan David Investments LLC IL purchased a new stake in McKesson during the 2nd quarter worth approximately $238,000. Finally, Newbridge Financial Services Group Inc. raised its position in shares of McKesson by 2,143.1% in the 2nd quarter. Newbridge Financial Services Group Inc. now owns 1,458 shares of the company’s stock valued at $851,000 after purchasing an additional 1,393 shares in the last quarter. 85.07% of the stock is owned by institutional investors and hedge funds.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Monday, December 2nd will be issued a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a yield of 0.47%. The ex-dividend date is Monday, December 2nd. McKesson’s dividend payout ratio is presently 14.71%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.